NEW FALL OPPORTUNITIES
Aging
American Federation for Aging Research
- CART Fund
- Research Grants
- Breakthrough in Gerontology Award
- Ellison/Julie Martin Mid-Career Award in Aging Research
Animal Science
American College of Laboratory Animal Medicine (ACLAM) Foundation
Blood Disorders
National Blood Foundation
Cancer
Sidney Kimmel Foundation for Cancer Research
Friends for an Earlier Breast Cancer Test
Alex's Lemonade Stand Foundation (ALSF)
- 2012 Innovation Award
- Epidemiology Awards
- Young Investigator Awards
Melanoma Research Alliance (MRA)
Clinical Medical Research
Doris Duke Clinical Scientist Development Award
Cystic Fibrosis
Cystic Fibrosis (CF) Foundation
Diabetes
Juvenile Diabetes Research Foundation (JDRF)
Family Medicine
American Academy of Family Physicians (AAFP) Foundation
Heart Disease Research
Myocarditis Foundation (MF) Research Fellowship Grant Infant and Children’s Health
HIV/AIDS Research
amfAR AIDS Research – Targeted Biomedical Research
Immunizations
Bill and Melinda Gates Foundation Grand Challenges
Liver Disease
American Liver Foundation (ALF)
Medical Education
Philip Manning Research Grant in Continuing Medical Education
Infant & Children’s Health
Aetna Foundation
Bill and Melinda Gates Foundation Grand Challenges Explorations
Gerber Foundation
Muscular Dystrophy
Muscular Dystrophy Association (MDA)
Neuroscience Research
The Dana Foundation -- Clinical Neuroscience Research Proposals
Parkinson's Disease
Parkinson's Disease Foundation
Michael J. Fox Foundation (MJFF) for Parkinson's Research
Patient Health and Safety
Cardinal Health Foundation
Psychiatry
Klingenstein Third Generation Foundation: Fellowship in Child & Adolescent ADHD; Fellowship in Child & Adolescent Depression
Rheumatology
American College of Rheumatology Research and Education Foundation (ACR REF)/Arthritis Foundation (AF)
Suicide Prevention
American Foundation for Suicide Prevention (AFSP)
Women’s Health
Anna Lalor Burdick Program
AGING
American Federation for Aging Research (AFAR)/CART Fund
Deadline: December 1, 2011 (LOI)
Funding: $250,000 max for up to 2 years
Purpose: The Rotary clubs in the states of Georgia and the two Carolinas as well as a number of individual clubs throughout the United States, with the assistance from the American Federation of Aging Research, established in 1996 a new funding program called The CART Fund. The goal of the fund is to encourage exploratory and developmental Alzheimer's Disease research projects within the United States by providing support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data but have the potential to substantially advance biomedical research.
Link: http://www.afar.org/research/funding/cart-fund
Go to Top
AFAR Research Grants
Deadline: December 15, 2011 at 5 p.m.
Funding: up to $100,000 over 1-2 years
Purpose: AFAR provides up to $100,000 for a one- to two-year award to junior faculty (M.D.s and Ph.D.s) to conduct research that will serve as the basis for longer term research efforts. AFAR-supported investigators study a broad range of biomedical and clinical topics including the causes of cellular senescence, the role of estrogen in the development of osteoporosis, the genetic factors associated with Alzheimer's disease, the effects of nutrition and exercise on the aging process, and much more.
Link: http://www.afar.org/research/funding/afar-research-grants
Go to Top
AFAR/Glenn Foundation for Medical Research/ Breakthrough in Gerontology Award
Deadline: December 15, 2011 at 5 p.m.
Funding: up to $200,000 over 2 years
Purpose: The "Breakthroughs in Gerontology" (BIG) initiative provides timely support to a small number of pilot research programs that may be of relatively high risk but which offer significant promise of yielding transforming discoveries in the fundamental biology of aging. The hope is that one or more of the funded research projects will lead to major new insights into the molecular factors that coordinate aging in multiple cells and tissues, and the ways in which the aging process is differentially timed in long-lived species. Projects that focus on genetic controls of aging and longevity, on delay of aging by pharmacological agents or dietary means, or which elucidate the mechanisms by which alterations in hormones, anti-oxidant defenses, or repair processes promote longevity are all within the intended scope of this competition. Projects that focus on specific diseases or assessment of health care strategies will receive lower priority, unless the research plan makes clear and direct connections to fundamental issues in the biology of aging.
Eligibility: Applicants must at the time they submit their proposal be full-time faculty members at the rank of Assistant Professor or higher. A strong record of independent publication beyond the postdoctoral level is a requirement. Applications from individuals not previously engaged in aging research are particularly encouraged, as long as the research proposals show high promise for leading to important new discoveries in biological gerontology.
Link: http://www.afar.org/research/funding/big
Go to Top
Ellison Medical Foundation/AFAR/Julie Martin Mid-Career Award in Aging Research
Deadline: December 15, 2011 at 5 p.m.
Funding: $500,000 over 4 years
Purpose: This program was designed for outstanding mid-career scientists who propose new directions of high importance to biological gerontology. Proposals in areas where NIH awards or other traditional sources are unlikely because the research is high risk, are particularly encouraged if they have the potential for leading to major new advances in our understanding of basic mechanisms of aging. Projects investigating age-related diseases are also supported, but only if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders are also encouraged, as long as these include connections to fundamental problems in the biology of aging. Projects that deal strictly with clinical problems such as the diagnosis and treatment of disease, health outcomes, or the social context of aging are not eligible.
Eligibility: The applicant must be an Associate Professor who achieved tenured status after December 1, 2008. Scientists not previously engaged in aging research, but whose research could lead to novel approaches in aging are eligible. Scientists already engaged in aging research but whose proposed research is a new high-risk direction of investigation with a potential high payoff in our understanding of basic aging processes, are also eligible. Recipients, past or present, of the Ellison Medical Foundation Senior Scholar Award in Aging are not eligible to apply for this award.
Link: http://www.afar.org/research/funding/midcareer
Go to Top
ANIMAL SCIENCE
American College of Laboratory Animal Medicine (ACLAM) Foundation
Deadline: December 9, 2011 (LOI)
Funding: up to $30,000
Purpose: The Mission of the ACLAM Foundation is to expand the body of knowledge in the fields of laboratory Animal Science and Medicine through funding research grants. The Foundation will fund studies in the following six laboratory animal research subjects:
- Analgesia/anesthesia
- Behavior/well-being
- Diagnostics/diseases
- Husbandry
- Refinement of animal models
- Zoonotic Disease
Successful grantees are encouraged to publish their results in peer-reviewed journals and must agree to provide summary research reports in lay language suitable for inclusion in ACLAM Foundation communications, fund raising solicitations and the ACLAM Newsletter.
Eligibility: The principal investigator (PI) must hold a doctoral-level degree (D.V.M./V.M.D., M.D., D.D.S., Ph.D. or equivalent). The one exception is in the husbandry area. A principal investigator with B.S., M.S. or A.A.L.A.S. Technologist certificate may apply.
Link: http://www.aclam.org/foundation
Go to Top
BLOOD DISORDERS
Bayer Hemophilia Awards: Special Project, Early Career and Clinical Training Awards
Deadline: November 30, 2011 (LOI); Full Proposals submitted March/April 2012.
Funding: Special Project, up to $200,000;
Early Career and Clinical Training, $100,000 yr/2 yrs.
Purpose: Special Project (SP) Award supports a wide range of research projects in the field of hemophilia. Examples include, but are not limited to: Clinical research, Basic research, Assessment and intervention in psychosocial issues facing patients and their families, Assessment of quality of life and other health economic outcomes in patients with bleeding disorders, and the effects of treatment modalities on such outcomes. Encourages hypothesis-driven research, not studies of the collection of epidemiological data.
Early Career (EC) Award funds salary and research funds for junior faculty member undertaking mentored basic and/or clinical research project in the bleeding disorders field. Examples include, but are not limited to: clinical studies, properties and delivery of clotting factor proteins, assays and models, genetics and epidemiology, molecular aspects and mechanisms of clotting factor inhibitor formation. Clinical Training (CT)Awards facilitates development of specific clinical expertise in field of hemophilia for applicants who have completed medical training w/interest in pursuing careers as hemophilia clinician. Supports mentored physician in training for 2 years. Clinical duties encompass diagnosis, evaluation, and planning of management strategies for patients with hereditary bleeding disorders.
Eligibility: For SP, individuals affiliated with a facility that carries out research in inherited bleeding disorders, or provides care to patients with those disorders. For CT awards, applicant should have earned medical degree within last 8 eight years; may not have received previous CT award funding. For EC award, applicant should have an entry-level academic or clinical appointment within his or her institution. Award open to applicants w/medical degree and/or PhD. who have earned terminal degree within previous 10 years. Special dispensation considered for extenuating circumstances.
Link: http://www.bayer-hemophilia-awards.com/awards.cfm#early
Go to Top
National Blood Foundation
Deadline: December 30, 2011
Funding: $75,000 over one to two years
Purpose: Since 1985, the National Blood Foundation (NBF) has awarded $7 million in grants to 171 scientific researchers. The important focus of research is transfusion medicine, to include aspects of immunology, hematology, tissue and transplantation medicine, cellular therapies, emerging infectious disease, immunohematology, donor health, and implementation of technological devices. Priority is given to new investigators and innovative projects with the potential to have a practical impact on patients and donors in these areas. Important areas of research for the grant program include:
- Immunology: Alloimmunization, immune modulation, and tolerance, animal models for the study of graft-vs-host disease, biology of autoimmune hemolytic anemia
- Hematology :Autologous and allogeneic stem cell transplants, detection of residual disease following stem cell transplants, effects of growth factors in vitro and in vivo, biochemistry of coagulation factors
- Immunohematology: Blood group serology, biochemistry of red cell antigens, molecular genetics of the blood groups
- Infectious diseases: Studies on Lyme disease, West Nile Virus, SARS and babesiosis and other emerging diseases, effect of allogeneic transfusion in HIV-infected and immunocompromised patients, improved detection of transfusion - transmitted diseases
- Cellular Therapies: Cell separation, cell culture or expansion studies for cell therapy applications, development of novel cell therapies or assays to measure cell viability or function, pilot studies in regenerative medicine, studies on mechanisms or roles of cells in stem cell transplantation, studies on cytokines or growth factors involved in stem cell differentiation
Eligibility: An applicant can be a doctor (M.D. or Ph.D.), medical technologist preferably with an advanced degree, or any transfusion medicine professional working in the U.S. or outside the U.S. Emphasis will be given to first time applicants who are no more than five years post training or second time applicants who have submitted a strong progress report. More experienced researchers who are changing fields to transfusion medicine and cellular therapies are also eligible for funding. Priority in awarding grants will be given to innovative, new projects.
Link: http://www.aabb.org/programs/nbf/Pages/grants.aspx
Go to Top
CANCER
Sidney Kimmel Foundation for Cancer Research
Deadline: December 1, 2011
Funding: $200,000 over two years
Purpose: The Kimmel Scholar Award is for young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2008. However, physicians who have both clinical and research responsibility are eligible if appointed on or after July, 2007. These awards are designed for researchers who do not yet have their own R01 funding. Applicants will be judged on the basis of quality of prior work, research proposed and letters of support.
Link: http://www.kimmel.org/Application_Process37.html
Go to Top
Friends for an Earlier Breast Cancer Test
Deadline: December 1, 2011
Funding: $40,000 over 1-3 years
Purpose: Friends for an Earlier Breast Cancer Test is a non-profit organization dedicated to promoting awareness and education and to raising funds for research into earlier detection of breast cancer. The organization is requesting applications for pilot projects that focus on new methods to improve detection of early breast cancer and are especially interested in the development of new techniques in the areas of biological or immunologic methods of early detection. It is hoped that pilot projects will provide preliminary data that leads to applications for more substantial peer-reviewed funding.
Eligibility: Applications are accepted from both established investigators who have funding but want to embark on a new area, as well as those less experienced. In either case, the proposal should represent a new approach to the area of interest.
Funds will not be given to enhance ongoing research unless it is clear that a new line of inquiry is being explored.
Link: http://www.earlier.org/grants-and-research/for-researchers
Go to Top
Alex's Lemonade Stand Foundation (ALSF) 2012 Innovation Award
Deadline: December 1, 2011 (LOI)
Funding: $100,000 for up to two years
Purpose: Designed as seed funding for mid-career researchers with a novel approach to pediatric cancer scientific investigation. This may often represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research. ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers.
Eligibility: Assistant, Associate or Full Professor level and may be M.D. or Ph.D.
Note: No medical grant applications in psychosocial aspects of pediatric cancer and/or cancer control.
Link: http://www.alexslemonade.org/files/LOI%20INN%20Guidelines%2009_16_11.pdf
Go to Top
Alex's Lemonade Stand Foundation (ALSF) Epidemiology Awards
Deadline: December 15, 2011
Funding: $100,000
Purpose: To support the research of investigators who have a specific focus on the epidemiology, early detection, or the prevention of childhood cancer. ALSF will award support to established investigators who have a track record of peer-reviewed publications in relevant areas. Provide additional funds that will allow investigators to pursue novel and promising approaches to understanding the cause of childhood cancers and how such insight can be used for early detection or prevention of childhood cancer. Eligible areas of investigation include epidemiology and etiology of childhood cancer; early detection of childhood cancer; prevention of childhood cancer; and some preclinical research.
Eligibility: Late Assistant, Associate or Full Professor level; M.D. or Ph.D.; history of formal training in disciplines relevant to the proposed research or a track record of conducting similar research.
Link: http://www.alexslemonade.org/files/2012%20EPI%20Guidelines%2061611.pdf
Go to Top
Alex's Lemonade Stand Foundation (ALSF) Young Investigator Awards
Deadline: December 15, 2011
Funding: $50,000
Purpose: Young Investigator Awards are designed as start-up funds for new scientists at the end of their fellowship training or early in their research career. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application.
Eligibility: Applicants should be at the early stages of their research careers as defined below:
- M.D. (D.O.) or M.D.,Ph.D. applicants must either be finished the third year of an accredited fellowship program at the time funding will start or within six years from the completion of a three-year fellowship program at the time the funding will start.
- Ph.D. applicants must be within six years from the granting of the Ph.D. at the time the funding will start, i.e. those with Ph.D. received in 2006 are eligible to apply for a 2012 grant. Post-docs are encouraged to apply but must also be within the six year time frame.
The applicant must not currently hold an independent NIH grant (R or P Award). Applicant may currently have a NIH K Award. A research mentor must be identified and the application must document his/her involvement in experimental design and execution.
Link: http://www.alexslemonade.org/files/2012%20YIA%20Guidelines%2009_16_11.pdf
Go to Top
Melanoma Research Alliance (MRA)
Deadline: December 1, 2011 at 5 p.m.
Funding: $50,000 (Pilot Awards); $75,000 (Young Investigator Awards); $125,000 (Established Investigator Awards); $100,000-$200,000 (Academic-Industry Partnerships
Purpose: Address the gap in translational science, i.e., turning scientific discoveries into tools and/or treatments for high risk individuals or melanoma patients. Proposals will be accepted for Individual Investigator Awards: Young Investigator Awards, Established Investigator Awards, Pilot Awards, and Partnership Awards. Successful proposals will offer the potential for translational development that could lead to high impact near-term clinical application in areas of melanoma prevention, diagnosis, staging, and treatment. Proposals for clinical investigations testing well defined and clearly articulated hypotheses are welcome and should be accompanied by a protocol synopsis; local IRB approval is not required at the time of application but is required in order to grant the award. Development and/or use of novel technologies that have the potential to further such advances in areas of emphasis described below will be considered:
- Prevention: Areas of interest include environmental, epidemiological, and biological factors in melanoma carcinogenesis.
- Diagnosis and Staging: Emphasis includes identification of serological tumor markers, association of molecular tumor biomarkers with prognosis, and development of novel clinical methods for melanoma detection and imaging.
- Treatment: Projects emphasizing the translation of scientific findings to the treatment of patients with melanoma are solicited. Examples include but are not limited to studies of melanoma immunotherapy, therapeutic applications based on molecular mechanisms involved in melanoma formation and/or progression, and development of novel biomarkers of response to therapy.
Eligibility: Principal Investigators (PIs) must hold a faculty appointment at an academic research institution at the level of Assistant Professor (or equivalent) or above. Investigators need not be specifically trained in melanoma research; however, they should be working in an environment capable of conducting high quality, high impact melanoma research. PIs must be able to show clear evidence of an independent research program. Fellows or those in other training positions are not eligible. Multiple applications will be accepted from a single institution, provided that each application has a different PI and represents a distinct hypothesis. Only one proposal per PI will be accepted.
Link: http://www.curemelanoma.org/research/research.taf?cat=rfp
Go to Top
CLINICAL MEDICAL RESEARCH
Doris Duke Clinical Scientist Development Award
Deadline: November 16, 2011for Nominations. Nominations must be submitted online on or before 5 p.m. Applicants must be nominated by DUCOM: Request a Nomination. Only 2 nominations/college/year. Full applications must be submitted by nominees on or before 5 p.m., December 21, 2011.
Funding: $150,000 direct costs plus $12,000 (8%) indirect costs per year for 3 years ($4
Purpose: Clinical Scientist Development Award program aims to enable promising early career physician-scientists to attain independent research program grant funding and to build successful careers in clinical research.
Eligibility: PhD., MD, other professional.
Link: http://www.ddcf.org/mrp-csda
Go to Top
CYSTIC FIBROSIS
Cystic Fibrosis (CF) Foundation
Deadline: December 1, 2011 at 5 p.m. (LOI)
Funding: up to $300,000 over three years
Purpose: Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the CF Foundation, offers competitive awards to support clinical research projects directly related to CF treatment and care. Projects may address diagnostic or therapeutic methods related to CF or the pathophysiology of CF, and applicants must demonstrate access to a sufficient number of CF patients from CF Foundation-accredited care centers and to appropriate controls.
Link: http://www.cff.org/research/ForResearchers/FundingOpportunities/
ClinicalResearchAwards/
Go to Top
DIABETES
Juvenile Diabetes Research Foundation (JDRF)
Deadline: November 28, 2011 (LOI)
Funding: $100,000-$250,000 per year over 1-2 years
Purpose: The Juvenile Diabetes Research Foundation and Sanofi, a multinational pharmaceutical company committed to innovative therapies for diabetes management, invite applications from single investigators or groups of investigators to identify and characterize cellular targets and mechanisms to promote beta cell neogenesis and transdifferentiation for regenerative therapies for the treatment of insulin-dependent diabetes.
Eligibility: Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent academic degree and a faculty position or equivalent at a college, university, medical school, or comparable institution.
Link: http://www.jdrf.org/files/General_Files/For_Scientists/MS2011/Neogenesis_
RFA_9_6_2011_FINAL_DRAFT.pdf
Go to Top
FAMILY MEDICINE
American Academy of Family Physicians (AAFP) Foundation
Deadline: Dec 01, 2011 (Application)
Funding: $50,000
Purpose: Supports research that poses questions of high relevance to family medicine…to the practicing family physician, encouraging proposals by junior investigators, funding pilot studies.
Eligibility: Individual family physicians, Family medicine organizations or associations, Family medicine residency programs, Departments of family medicine, Educational and health care institutions or organizations that will use the JGAP support exclusively for research projects directly involving and impacting family medicine. PI or one of co-investigator must be an AAFP member. JGAP encourages submission of proposals w/family physician as PI. Priority given to new researchers or those who mentor new investigators on the research team.
Link: www.aafpfoundation.org/online/foundation/home/awards-and-grants/
individuals/jointgrants.html
Go to Top
HEART DISEASE RESEARCH
Myocarditis Foundation (MF) Research Fellowship Grant
Deadline: December 15, 2011 (Full Proposal)
Funding: $35,000
Purpose: MF awards funds to support research related to all forms of myocarditis, with goal to advance medical knowledge on the disease and develop more accurate diagnostic methods and life-improving therapies with the goal of saving more lives. Fund innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. Grant designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by NIH/other major institutions. Research may involve human subjects and animal subjects.
Eligibility: May apply up to 10 years after earning M.D., Ph.D., or equivalent degree, plan to perform the funded work in the US or Canada. Must select preceptor with proven research track record in myocarditis.
Link: http://myocarditisfoundation.org/research/
Go to Top
HIV/AIDS RESEARCH
amfAR AIDS Research – Targeted Biomedical Research
Deadline: October 25, 2011 by 5 pm (LOI)
Funding: Up to $250,000 over two years (plus 20% in indirect costs)
Purpose: To support basic, clinical, and translational research exploring the mechanisms whereby HIV infections persists; the chronic nature of viral reservoirs and latency, and barriers to the eradication of HIV with the potential goal of ultimately eliminating HIV infection.
Specific areas of interest include:
- Novel strategies/approached for preventing the establishment of, or eliminating viral reservoirs;
- Understanding and characterizing cellular and tissue locations of reservoirs, and their relative importance in maintaining infection in the face of antiretroviral therapy (ART) and the immune system;
- Studies in elite controllers and/or acute (i.e. the absence of antibody positivity) infection cohorts that may help define new mechanisms of persistence that are not HLA-driven;
- Improved assays to more efficiently and inexpensively measure extremely low viral load (e.g. to 0.01 copies/ml) or (changes in) the size of the persistent reservoir; and
- Deep sequencing approaches to compare viruses in different tissue compartments with those in plasma following treatment interruption, with a view to identifying sources of viral rebound.
Eligibility: Applicants must be principal or collaborating investigators and must hold a doctoral degree.
Note: Submit complete Letter of Intent to grants@amfar.org.
Link: http://www.amfar.org/lab/grants/default.aspx?id=10364
Go to Top
IMMUNIZATION RESEARCH
Bill and Melinda Gates Foundation--Grand Challenges Explorations
Deadline: November 17, 2011
Funding: $100,000
Purpose: Grand Challenges Explorations fosters innovation in global health research. The Bill & Melinda Gates Foundation has committed $100 million to encourage scientists worldwide to expand the pipeline of ideas to fight our greatest health challenges. Phase I grants of $100,000are awarded initially; projects have one opportunity to apply for a follow-on Phase II grant of up to $1,000,000. Proposals for Grand Challenges Explorations Round 8 grants are being accepted for the following topics:
- Protect Crop Plants from Biotic Stresses From Field to Market
- Design new approaches to optimize immunization systems
- Explore New Solutions in Global Health Priority Areas
- Explore Nutrition for Healthy Growth of Infants and Children
- Apply Synthetic Biology to Global Health Challenges
Eligibility: Grand Challenges Explorations is open to both foreign and domestic non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions. Grants will not be provided to individuals.
Link: http://www.grandchallenges.org/Explorations/Pages/ApplicationInstructions.aspx
Go to Top
INFANT/CHILDREN’S HEALTH
Aetna Foundation
Deadline: LOIs accepted on a rolling basis; full proposals due November 15, 2011
Funding: $25,000-$250,000
Purpose: The Aetna Foundation is interested in how to improve health and health care among the nation’s Medicaid population, particularly in settings with large numbers of minority patients. The Foundation also wants to drive improvement in one of the longest-standing disparities in health care -- infant mortality. Examples of supported grants include projects and/or studies to:
- Explore how a stronger primary care model and relationships with providers could benefit minority populations and close the persistent health care gap
- Help providers who treat large minority populations become leaders in delivering high-quality care
- Determine what can be done to reduce the numbers of low-birth weight babies born to mothers at risk
- Examine, through observational studies, the correlation between a mother’s health, stress level, and social supports; and the likelihood of having a healthy baby who lives through its first year of life
- Determine, through interventional studies, whether stress-reduction programs (including yoga and meditation) can improve health outcomes for minority patients with chronic conditions, as well as postnatal outcomes for mothers and pregnant women
Aetna also seeks to support projects that promote evidence-based models of care coordination that can lead to high-quality, patient-centered health care services, improve health outcomes and lower costs. The goal is to demonstrate the key components, best practices and benefits of care coordination that is centered on strong primary care. Examples of supported grants include projects or studies that:
- Develop standards and metrics of care coordination in ambulatory care settings.
- Evaluate models of care coordination that enhance providers’ communication with each other and with their patients and lead to improved patient outcomes and experiences with their care.
- Evaluate methods of care coordination for engaging patients as partners in their care, particularly in the management of chronic conditions.
- Identify best practices to align financial and other incentives for achieving well-coordinated care.
- Identify and assess models of care coordination that reduce the cost of care while improving patient health outcomes.
Eligibility: Only one grant per organization in a calendar year. If you have been funded by Aetna/Aetna Foundation in the past 24 months you must make sure your progress reporting requirements are up to date. You can include an update on these grant activities with your application.
Link: http://www.aetna-foundation.org/foundation/aetna-foundation-programs/
program-areas/program-areas-overview.html
Go to Top
Bill and Melinda Gates Foundation--Grand Challenges Explorations
Deadline: November 17, 2011
Funding: $100,000
Purpose: Grand Challenges Explorations fosters innovation in global health research. The Bill & Melinda Gates Foundation committed $100 million to encourage scientists worldwide to expand pipeline of ideas to fight greatest health challenges. Phase I grants of $100,000 awarded initially; projects have one opportunity to apply for follow-on Phase II grant of up to $1,000,000. Proposals for Grand Challenges Explorations Round 8 grants accepted for the following topics:
- Protect Crop Plants from Biotic Stresses From Field to Market
- Design new approaches to optimize immunization systems
- Explore New Solutions in Global Health Priority Areas
- Explore Nutrition for Healthy Growth of Infants and Children
- Apply Synthetic Biology to Global Health Challenges
Eligibility: Grand Challenges Explorations is open to both foreign and domestic non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions. Grants will not be provided to individuals.
Link: http://www.grandchallenges.org/Explorations/Pages/ApplicationInstructions.aspx
Go to Top
Gerber Foundation
Deadline: December 1, 2011 (concept paper)
Funding: up to $300,000
Purpose: Health and nutritional issues affecting infants and young children. Research projects aimed at finding solutions to children’s health and nutritional problems are sought. Of particular interest are those offering a substantial promise of meaningful advances in prevention and treatment of diseases and those with broad applicability to the general population. Interests include:
- Pediatric health—reducing the incidence of serious neonatal and early childhood illnesses, or improving cognitive, social and emotional aspects of development
- Pediatric nutrition—applied research that evaluates the provision of specific nutrients and their related outcomes in infants and young children
- Environmental hazards (nutrient competitors)—applied research projects that document the impact of, or ameliorate effects of, environmental hazards on the growth and development of infants and young children
Link: http://www.gerberfoundation.org/
Go to Top
LIVER DISEASE
American Liver Foundation (ALF)
Deadline: December 1, 2011 at 5 p.m.
Funding: $225,000 over three years
Purpose: The Liver Scholar Award provides young scientists with support for their research to bridge the gap between completion of research training and attainment of status as an independent research scientist. The additional research experience provided by this award is intended to enable them to successfully compete for research awards from national sources, particularly the NIH. Well-trained investigators who hold M.D., Ph.D. or M.D./Ph.D. degrees and are pursuing a career in liver disease research are encouraged to apply. The Liver Scholar Award is intended to develop the potential of outstanding, young scientists and encourage research in liver physiology and disease. Individuals who are already well-established in the field are not eligible for this award.
Eligibility: Applicants must meet the following guidelines in order to be eligible for the Liver Scholar Award:
- Applicant must be sponsored by a public or private non-profit institution accredited in the United States, Canada or Mexico engaged in health care and health-related research.
- Applicant must apply within the first three (3) years of his/her first faculty appointment (including prior appointments in universities outside of North America) and commence the award within the first four (4) years of faculty appointment.
- If the applicant does not have a faculty appointment at the time of application, a letter signed by the department chair confirming that the applicant will have a faculty appointment (a) no later than the Liver Scholar Award start date and (b) for the full award cycle must be submitted.
- At the time of application or during an ALF Liver Scholar Award cycle, the applicant cannot hold or have held any of the following awards: NIH R01, PO1, R29, K01, K08, K11 or R21 award; Veterans Administration Merit Review, Associate Investigator, Research Associate, or Clinical Investigator Award; AGA Industry Award, Glaxo Institute for Digestive Health Award; American Heart Association Award, or any other similar award that is intended to primarily support the salary of young investigators.
- ALF must be notified immediately if the applicant receives another research award during the application process or after the receipt of an award.
- Applicant must be an AASLD member in good standing by the award start date and maintain active membership for the duration of the award period (July 1, 2012 – June 30, 2015). If applicant is not a member at the time of application, a membership application must be submitted with application.
- Applicant must be sponsored by a research mentor. The mentor must be an AASLD member in good standing at the time of application and maintain active membership for the duration of the award period (July 1, 2012 – June 30, 2015). If mentor is not a member at the time of application, a membership application must be submitted separately by December 1.
- Co-mentors who are not AASLD members are encouraged to obtain membership.
- Applicant may only apply for one award or fellowship offered by ALF and AASLD.
Link: http://www.liverfoundation.org/2012_research_awards/
2012_liver_scholar_award/
Go to Top
MEDICAL EDUCATION
Philip Manning Research Grant in Continuing Medical Education
Deadline: Dec 20, 2011 Anticipated LOI; Mar 30, 2012 Application
Funding: $50,000 across 2 years
Purpose: Original research studies related to physician life-long learning and physician change. Proposals must use either quantitative or qualitative methods in a rigorous scientific design. The finished work must be appropriate for publication in a peer-reviewed journal and for presentation at a SACME meeting.
Eligibility: members of LCME-accredited organizations, medical specialty societies, NCQA-accredited organizations, the Alliance for CME, Association for Hospital Medical Education, and others interested in advancing CME research.
Link: http://www.sacme.org/grants
Go to Top
MUSCULAR DYSTROPHY
Muscular Dystrophy Association (MDA)
Deadline: December 15, 2011 (LOI)
Funding: $60,000 per year for 1-3 years
Purpose: MDA supports research aimed at developing treatments for the muscular dystrophies and related diseases of the neuromuscular system. These are the muscular dystrophies (among which are Duchenne and Becker); motor neuron diseases (including ALS and SMA); the peripheral nerve disorders (CMT and Friedreich's ataxia); inflammatory myopathies; disorders of the neuromuscular junction; metabolic diseases of muscle as well as other myopathies.
Eligibility: Applicants must hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.); be a professional or faculty member (Professor, Associate Professor or Assistant Professor) at an appropriate educational, medical or research institution; be qualified to conduct and mentor a program of original research within their own laboratory; assume both administrative and financial responsibility for the grant; and have access to institutional resources necessary to conduct the proposed research project.
Link: http://www.mdausa.org/research/guidelines.html
Go to Top
NEUROSCIENCE
The Dana Foundation -- Clinical Neuroscience Research Proposals
Deadline: Requests will be reviewed on a rolling basis. (LOI)
Funding: Up to $300,000 payable over three years
Purpose: "First in man" studies of patients with devastating brain diseases for which there currently is no effective treatment. "Controlled clinical studies" in patients with specific brain disease, based on promising animal studies suggesting a specific therapy either treated condition or prevented it from worsening.
Eligibility: Clinical researchers.
Link: http://www.dana.org/grants/clinical/
Go to Top
OTOLARYNGOLOGY
Triological Society Research Career Development Awards
Deadline: December 15, 2011 (LOI); Applications due January 17, 2012
Funding: Up to $40,000 over a one or two year period.
Purpose: Research Career Development Awards are available to otolaryngologists who hold full-time, part-time and contributed service medical school faculty appointments, and who have made a commitment to focus on patient-oriented research. Awards provide support for research career development.
Eligibility: PhD., MD, other professional.
Link: http://www.triological.org/researchgrants.htm
Go to Top
PARKINSON'S DISEASE
Parkinson's Disease Foundation (PDF)
Deadline: November 15, 2011 at 5 p.m. (LOI)
Funding: $75,000 over two years
Purpose: The Foundation's International Research Grants Program (IRGP) is designed to promote innovative research that has a high potential to significantly advance the knowledge of Parkinson's disease (PD) but little likelihood of securing funding through more traditional sources. By supporting novel, "high risk/high reward" research, the goal of the IRGP is to enable investigators to demonstrate the feasibility of their ideas while generating preliminary data necessary for the support of future funding. Successful IRGP projects are:
- novel research hypotheses of Parkinson's disease;
- inventive in terms of methodology or approach; and
- clinical, preclinical, or basic research proposals that will directly impact Parkinson's disease or its treatment.
Eligibility: The IRGP is open to independent investigators both nationally and internationally, possessing postdoctoral training or a medical degree, with clinical, preclinical or basic research proposals that will directly impact Parkinson's disease or its treatment. Preference will be given to scientists who are at an early stage in their professional careers. Postdoctoral researchers/scientists and fellows are not eligible to apply for this program. Investigators who receive funding from PDF may not receive funding for other projects supported by PDF during the same year, nor receive funding from other foundations or institutions for the same project during that year.
Link: http://www.pdf.org/en/grant_funding_irg
Go to Top
Michael J. Fox Foundation (MJFF) for Parkinson's Research
Deadline: November 29, 2011 at 6 p.m. (Target Validation pre-proposal). No deadlines for Rapid Response.
Funding: $75,000 over one year for Rapid Response; $250,000 over two years for Target Validation
Purpose: The Edmond J. Safra Core Programs for PD Research, part of MJFF‘s annual Pipeline Programs, represents funding opportunities focused on the following critical points along the translational pathway to new Parkinson's Disease (PD) therapies:
- Rapid Response Innovation Awards: This program quickly supports high-risk, high-reward projects with little to no existing preliminary data, but potential to significantly impact our understanding or treatment of PD.
- Target Validation: This program supports work seeking to determine if modulation of a novel biological target has impact in a PD-relevant animal model – an essential early step to the development of potential targeted therapies.
Eligibility: The following restrictions apply to the Principal Investigator (PI) who submits a proposal:
- For Target Validation Awardspost-doctoral fellows are NOT eligible to apply as PIs.
- For the Rapid Response Innovation Awardsprogram post-doctoral fellows are eligible to apply as PIs, but must collaborate with an Administrative PI who serves as the director of the laboratory in which the research will be conducted. The Administrative PI will be responsible for assisting in providing all institutional documents required for the project and will be required to sign any award contract. Biographical information is required for both the postdoctoral fellow acting as PI, as well as for the Administrative PI.
- Responsibility for the planning, direction, and execution of the proposed project will rest solely with the PIs.
- Training or mentoring-only proposals will not be considered
Link: http://www.michaeljfox.org/research_openFundingPrograms_
program.cfm?ID=45
Go to Top
PATIENT HEALTH & SAFETY
Cardinal Health Foundation
Deadline: December 02, 2011
Funding: $15,000 to $35,000
Purpose: To develop and support programs that help healthcare providers implement best practices that can truly transform patient care in areas of Medication safety across transitions of care; Implementation of WHO checklists in the operating room.
Eligibility: PhD., MD, other professional.
Link: http://www.cardinalhealth.com/us/en/CommunityRelations/Apply/E3
Go to Top
PSYCHIATRY
Klingenstein Third Generation Foundation: Fellowship in Child & Adolescent ADHD; Fellowship in Child & Adolescent Depression
Deadline: January 13, 2012 (Online Nominations Only from Chair of Departments of Psychiatry)
Fellowship Applications are due March 23, 2012
Funding: $30,000/yr for 2 yrs
Purpose: To support 2-year research projects that could lead to federal funding and other national research awards. Institutions should nominate candidates who have strong evidence of independent research ability and who are planning a career in research related to child and adolescent psychiatry.
Eligibility: Chair of Dept of Psychiatry should nominate 1 post-doc w/Ph.D. and/or M.D. who has completed all clinical training; should be at the junior faculty level, but will consider candidates in research training programs. Investigators who received R01 awards from NIMH are not eligible; those w/K awards or who applied for K awards or hope to use a KTGF fellowship as a stepping stone to K award or other funding are eligible. Fellow must have IRB approval beforereceiving award.
Link: http://www.ktgf.org/fellowship_prog.html
Go to Top
RHEUMATOLOGY
American College of Rheumatology Research and Education Foundation (ACR REF)/Arthritis Foundation (AF)
Deadline: December 30, 2011
Funding: $75,000 over 1 year
Purpose: The ACR REF/AF Career Development Bridge Funding Award provides bridge funding for promising investigators as they are revising outstanding career development awards (i.e., NIH K08/K23 awards or VA CDA-2 awards). Through this bridge funding award, the REF plans to support young faculty members so that they have the highest likelihood of achieving success in obtaining longer term career development awards. This funding mechanism is consistent with the REF goal of helping to ensure the future of academic rheumatology.
Eligibility: Applicants must be ACR or ARHP members with an M.D., D.O., Ph.D. or equivalent doctoral level degree from an accredited institution, M.D./Ph.D.s and D.O./Ph.D.s are eligible to apply. Applicants must have received a score on the latest of their initial or first re-submission of their K08, K23, or CDA-2 award. Past recipients of this award and applicants with A1 resubmission status are not eligible to apply.
Link: http://www.rheumatology.org/ref/awards/bfa.pdf
Go to Top
SUICIDE PREVENTION
American Foundation for Suicide Prevention (AFSP)
Deadline: November 15, 2011
Funding: $30,000-$225,000
Purpose: AFSP research grants support studies that aim to increase understanding of the causes of suicide and factors related to suicide risk or to test treatments and other interventions designed to prevent suicide. A suicide outcome measure must be included. Submitting treatment feasibility studies or adding a suicide component (e.g., sample or treatment) to an existing grant are also acceptable. AFSP offers the following types of grants:
- Pilot Grants (up to $30,000 over one or two years): awarded to investigators at any level. These grants provide seed money for new projects with the potential to lead to subsequent, larger investigations and are typically feasibility rather than hypothesis-driven studies.
- Standard Research Grants (up to $75,000 over two years): awarded to individual investigators at any level.
- Young Investigator Grants (up to $85,000 over two years): awarded to investigators at the level of assistant professor or lower. In addition to a maximum of $75,000 for the investigator’s research, these grants provide an additional $10,000 ($5,000 per year) for an established suicide researcher who will mentor the Young Investigator. AFSP can assist in matching mentors with mentees.
- Postdoctoral Research Fellowships (up to $100,000 over two years): awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have not had more than three years of fellowship support. Fellows receive a progressive stipend of $42,000 for the first year and $46,000 for the second year, with an institutional allowance of $6,000 per year.
- Distinguished Investigator Grants (up to $100,000 over two years): awarded to investigators at the level of associate professor or higher with an established record of research and publication on suicide.
- Linked Standard Research Grants (up to $225,000 over two years): awarded to investigators at any level performing research involving three or more unique sites.
Eligibility: Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, providing the study has an essential focus on suicide or suicide prevention. A currently-funded grantee may not submit a new application until completion of the ongoing grant and submission of a Final Report within the prescribed period (i.e., 60 days following grant completion or termination). New grantees must begin their studies within six months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.
Link: http://www.afsp.org/index.cfm?page_id=0535FDA2-FA7D-AAE8-D7A9A6BCFFE3574B
Go to Top
WOMEN’s HEALTH
Anna Lalor Burdick Program
Deadline: November 1, 2011 (concept paper)
Funding: $10,000-$50,000 for one year
Purpose: The Anna Lalor Burdick Program seeks to educate young women about healthy reproduction in order to broaden and enhance their options in life. The program focuses particularly on young women who have inadequate access to information regarding sexual and reproductive health, including comprehensive and unbiased information on contraception and pregnancy termination. Preference is given to the following types of programs:
- Sexual and reproductive health education should be the centerpiece of the program’s work
- Expanding young women’s reproductive options should be the target, but the program may involve young men as well for that purpose
- New programs or innovation in successful existing programs
- Well developed plans for sustainability
- Clear definition of project goals and intended outomes and a feasible plan to assess impact and success
- Collaborative efforts, including evidence of participation by proposed partner organizations
- Demonstration of plans to share outcomes and successful techniques or products
Link: http://66.147.244.193/~lalorfou/?page_id=9
Go to Top
